Lv5
840 积分 2024-11-21 加入
Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis
20小时前
待确认
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
22小时前
待确认
MAFLD: Renovation of clinical practice and disease awareness of fatty liver
9天前
已完结
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults
9天前
已完结
Epidemiological trends and clinical characteristic of NAFLD/MAFLD in Asia
9天前
已完结
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
9天前
已完结
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
25天前
已完结
Efecto de semaglutida sobre los biomarcadores de la enfermedad del hígado graso en pacientes con diabetes y obesidadEffect of semaglutide on fatty liver disease biomarkers in patients with diabetes and obesity
25天前
已关闭
Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers
26天前
已完结
皖公网安备34019202002308
